More specific phosphorylated TOPK (Y74) and (Y272) antibodies are needed urgently to be used in clinicopathological study in colon cancer, because accurate understanding TOPK activity in colon cancer patients will provide more valuable information. The gene discussed is PBK; the disease is colonic neoplasm.